Trial of Low-Dose 5-Fluorouracil/Cisplatin Therapy for Advanced Extramammary Paget's Disease

Dermatologic Surgery

Volumn 30, Issue 2 II, 2004, Pages 341-344

  Kariya, Kiyonori ^a   Tsuji, Takuo ^a   Schwartz, Robert A ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL;

ADRENAL METASTASIS; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; GENITAL SYSTEM; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LOW DRUG DOSE; LYMPH NODE METASTASIS; MALE; PAGET SKIN DISEASE; PENIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 1542348682     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200402002-00019     Document Type: Article

References (15)

1. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995;33:161-82.
2. Goldberg DJ, Nychay SG, Schwartz RA. Bilateral axillary extramammary Paget's disease treated with Mohs micrographic surgery. Chron Dermatol (Roma) 1996;6:659-67.
3. Koashi Y, Kitajima S, Schwartz RA, Tsuji T. Perianal Paget's disease years after rectal adenocarcinoma removal. Dermatol Surg 1997;23:1032-4.
4. Kitajima S, Yamamoto K, Tsuji T, Schwartz RA. Triple extramammary Paget's disease. Dermatol Surg 1997;23:1035-103.
5. Satoh Y, Une Y, Fujisawa J, et al. Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon. Jpn J Cancer Chemother 1995;22:87-92.
6. Balducci L, Athar M, Smith GF, et al. Metastatic extramammary Paget's disease: dramatic response to combined modality treatment. J Surg Oncol 1988;38:38-44.
7. Yokoyama Y, Mabuchi M, Kawabata I, et al. Metastatic vulvar Paget's disease responding to combination chemotherapy. Jpn J Clin Oncol 1990;20:426-30.
8. Holger V, Reinhard B, Walter N. Cytoreductive combination chemotherapy for regionally advanced unresectable extramammary Paget carcinoma. Cancer 1992;70:704-8.
9. Oguchi S, Kaneko M, Uhara H, et al. Docetaxel induced durable response in advanced extramammary Paget's disease. J Dermatol 2002;29:33-7.
10. Scanlon KJ, Newman EM, Lu Y, et al. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986;83:8923-5.
11. Shirasaka T, Shimamoto Y, Fukushima M, et al. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 1993;32:167-72.
12. Yamashita Y, Ohira M, Sowa M, et al. Low-dose FP therapy for advanced and recurrent gastric cancer. Jpn J Chemother 1999;26:1548-53.
13. Furuhata T, Hirata K, Yamamitu S, et al. Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma. Jpn J Cancer Chemother 1999;26:1554-8.
14. Tokuda Y, Oguchi S, Yamazaki Y, et al. Low dose FP (5-FU + low-dose CDDP) therapy for advanced extramammary Paget's disease. Jpn J Dermatol 1997;107:21-7.
15. Altomare GF, Frigerio E, Capella GL. Adenocarcinoma vulvare metastatico; un caso diagnosticato tardivamente, G Ital Dermatol Venereol 2003;138:319-71.